Northwestern Mutual Wealth Management CO Cel Sci Corp Transaction History

Northwestern Mutual Wealth Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	BUY	$1.99 - $3.52 $1,072 - $1,897	539 New	539 $1,000
Q4 2021 Feb 03, 2022	SELL	$7.1 - $12.82 $71,000 - $128,200	-10,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $76,400 - $124,900	10,000 New	10,000 $110,000
Q4 2019 Feb 13, 2020	SELL	$6.71 - $9.55 $6 - $9	-1 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	1	1 $0

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.